Sehoon Kim

Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli

M. Rosenblum, L. Cheung, Sehoon Kim, 2007, Applied Microbiology and Biotechnology.

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

Wei Zhang, L. Ramdas, W. Hittelman, 2011, BMC Cancer.

Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.

Yu Cao, J. Marks, M. Rosenblum, 2009, Cancer research.

Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.

Yu Cao, J. Marks, M. Rosenblum, 2009, Cancer research.

Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.

Kai Chen, Weibo Cai, Victor Tse, 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature

M. Rosenblum, Jun Yang, N. Navone, 2011, Clinical Cancer Research.

Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli.

M. Rosenblum, L. Cheung, Sehoon Kim, 2007, Journal of biotechnology.

Real-time imaging of glioblastoma using bioluminescence in a U-87 MG xenograft model mouse

Dong Jin Kim, H. Kim, Bo Ram Kang, 2015, Journal of the Korean Society for Applied Biological Chemistry.

Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET

J. Willmann, S. Gambhir, I. Y. Chen, 2008, Journal of Nuclear Medicine.

Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

B. Aggarwal, W. Hittelman, M. Rosenblum, 2010, Neoplasia.